Loading…
Mandatory review of a prescription drug monitoring program and impact on opioid and benzodiazepine dispensing
•Mandating Prescription Drug Monitoring Program (PDMP) checking was effective in reducing the quantity of opioids.•There was an 8.9% reduction in opioids dispensed.•There was a significant decline in multiple provider episodes.•As PDMPs’ functionality and utilization improve, they may be more effect...
Saved in:
Published in: | Drug and alcohol dependence 2018-07, Vol.188, p.169-174 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | •Mandating Prescription Drug Monitoring Program (PDMP) checking was effective in reducing the quantity of opioids.•There was an 8.9% reduction in opioids dispensed.•There was a significant decline in multiple provider episodes.•As PDMPs’ functionality and utilization improve, they may be more effective.
The purpose of this study is to determine whether Ohio House Bill 341, which mandated the use of Ohio’s Prescription Drug Monitoring Program (PDMP), was an effective regulatory strategy to reduce opioid and benzodiazepine dispensing.
Secondary analysis of Ohio’s PDMP data on prescription opioids and benzodiazepines dispensed from November 2014 to March 2017. An interrupted time series analysis was conducted to determine if there was a significant change in the quantity of opioids and benzodiazepines dispensed.
After HB341 became effective in April 2015, there was a statistically significant decrease in the monthly quantity (number of pills) opioids and benzodiazepines dispensed in Ohio. There was a modest increase in the mean days’ supply of opioids and no change in the mean morphine equivalent dose.
Legislation in Ohio requiring prescribers to check the PDMP was effective in reducing the quantity of opioids and benzodiazepines dispensed. |
---|---|
ISSN: | 0376-8716 1879-0046 |
DOI: | 10.1016/j.drugalcdep.2018.03.036 |